STIM (NeuroStar) Prakiraan pendapatan perusahaan
Neuronetics, Inc. (STIM) is retaining key engineers and expanding its sales agent workforce. This chart in the GURU.Markets terminal illustrates the organization's prospective sales volume, where 0.16 indicates the current level. Efficient equipment delivery supports margins; however, pressure from pharmaceuticals and complexities regarding insurance reimbursements create significant barriers to profit growth for Neuronetics, Inc. (STIM).
Rincian analitis lan laporan data perusahaan Neuronetics Inc. (STIM)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Neuronetics, Inc.|STIM - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal NeuroStar|STIM - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Neuronetics Inc.|STIM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Neuronetics|Indikator likuiditas cepet neurostar.com
- statistik bathi lan rasio pasar:
STIM - Bathi pungkasan|Proyeksi bathi mangsa ngarep Neuronetics, Inc.|STIM - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Neuronetics|STIM - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Neuronetics Inc.|STIM - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Neuronetics|STIM - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan neurostar.com|STIM - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Neuronetics, Inc.
- data dodolan lan asil:
Analisis fundamental perusahaan:Neuronetics, Inc.
Equipment and software deliveries for depression therapy from Neuronetics, Inc. (STIM) generate a steady revenue stream, which the estimated future sales metric currently prices in at 0.16. This metric reflects market expectations for operating cash flow through the discounting of prospects, where an upward trend on the chart confirms market share expansion, while a decline signals risks of overstocking and a loss of business margins.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan BSX (Boston Scientific)|EW (edwards.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan ResMed RMD|PODD - Volume dodolan mangsa ngarep perusahaan|Zimmer - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan CooperSurgical|ALGN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GMED|TMDX (TransMedics Group, Inc.) - Prakiraan volume dodolan|Alphatec Holdings (ATEC) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan AORT|Volume dodolan mangsa ngarep perusahaan Enovis Inc. ENOV|Prakiraan volume dodolan IART (Integra LifeSciences)|Prakiraan volume dodolan establishmentlabs.com ESTA|BBNX - Prakiraan pendapatan perusahaan|IRMD: Prakiraan pendapatan perusahaan|EMBC (Embecta Inc.) - Volume dodolan mangsa ngarep perusahaan|Tandem Corp - Pendapatan mangsa ngarep perusahaan|AXGN (AxoGen, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan si-bone.com SIBN|Prakiraan pendapatan perusahaan Orthofix (OFIX)|Bioventus Inc (BVS) - Prakiraan dodolan perusahaan|OrthoPediatrics - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Treace Corp TMCI|Strata Critical Medical Inc - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan carlsmed.com CARL|RxSight (RXST) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan CLPT (ClearPoint Neuro)|Prakiraan pendapatan perusahaan Stereotaxis Corp|Volume dodolan mangsa ngarep perusahaan Sight Sciences Inc (SGHT)|Prakiraan volume dodolan OBIO|ANIK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan InspireMD NSPR|ZJYL: Prakiraan pendapatan perusahaan|VANI: Volume dodolan mangsa ngarep perusahaan|Xtant Medical Holdings - Prakiraan volume pendapatan perusahaan|NeuroOne Medical Technologies (NMTC) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MODD|MYO (Myomo) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Envoy Medical Inc. COCH|Volume dodolan mangsa ngarep perusahaan VVOS (Vivos Therapeutics, Inc)|Prakiraan volume dodolan enVVeno Corp (NVNO)|Prakiraan pendapatan perusahaan Sintx Technologies, Inc. SINT|Pendapatan mangsa ngarep perusahaan TNON|LFWD - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Autonomix Medical, Inc.|INVO Bioscience, Inc. (IVF) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan BBLG|AXNX (Axonics, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan biolase.com BIOL|Volume dodolan mangsa ngarep perusahaan DYNT (Dynatronics Corporation)|Prakiraan volume pendapatan perusahaan FNA|Prakiraan volume dodolan INVO (INVO Bioscience)
